Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-02-14 10:23 am Unchanged | 13G | ADAPTIVE BIOTECHNOLOGIES CORP ADPT | VIKING GLOBAL INVESTORS LP | 29,993,708 20.7% | 0 (Unchanged) | View |
| 2024-02-13 4:55 pm Purchase | 13G | ADAPTIVE BIOTECHNOLOGIES CORP ADPT | VANGUARD GROUP INC | 12,767,684 8.82% | 973,516 (+8.25%) | View |
| 2024-01-29 4:00 pm Purchase | 13G | ADAPTIVE BIOTECHNOLOGIES CORP ADPT | ARK Investment Management LLC | 12,806,513 8.85% | 3,605,268 (+39.18%) | View |
| 2024-01-26 11:49 am Sale | 13G | ADAPTIVE BIOTECHNOLOGIES CORP ADPT | BlackRock Inc. BLK | 11,421,554 7.9% | -952,643 (-7.70%) | View |
| 2023-02-13 3:52 pm Purchase | 13G | ADAPTIVE BIOTECHNOLOGIES CORP ADPT | BlackRock Inc. BLK | 12,374,197 8.7% | 12,374,197 (New Position) | View |
| 2023-02-10 10:25 am Purchase | 13G | ADAPTIVE BIOTECHNOLOGIES CORP ADPT | ARK Investment Management LLC | 9,201,245 6.43% | 9,201,245 (New Position) | View |
| 2023-02-09 10:54 am Purchase | 13G | ADAPTIVE BIOTECHNOLOGIES CORP ADPT | VANGUARD GROUP INC | 11,794,168 8.25% | 762,880 (+6.92%) | View |
| 2022-09-12 2:07 pm Sale | 13G | ADAPTIVE BIOTECHNOLOGIES CORP ADPT | PRICE T ROWE ASSOCIATES INC | 4,081,518 2.9% | -10,159,096 (-71.34%) | View |
| 2022-02-14 5:02 pm Unchanged | 13G | ADAPTIVE BIOTECHNOLOGIES CORP ADPT | VIKING GLOBAL INVESTORS LP | 29,993,708 21.3% | 0 (Unchanged) | View |
| 2022-02-14 12:05 pm Sale | 13G | ADAPTIVE BIOTECHNOLOGIES CORP ADPT | Matrix Capital Management Company LP | 11,572,590 8.2% | -1,542,500 (-11.76%) | View |
| 2022-02-10 1:16 pm Purchase | 13G | ADAPTIVE BIOTECHNOLOGIES CORP ADPT | PRICE T ROWE ASSOCIATES INC | 14,240,614 10% | 953,901 (+7.18%) | View |
| 2022-02-10 1:13 pm Purchase | 13G | ADAPTIVE BIOTECHNOLOGIES CORP ADPT | PRICE T ROWE ASSOCIATES INC | 13,286,713 9.4% | 13,286,713 (New Position) | View |
| 2022-02-09 3:16 pm Purchase | 13G | ADAPTIVE BIOTECHNOLOGIES CORP ADPT | VANGUARD GROUP INC | 11,031,288 7.82% | 1,375,863 (+14.25%) | View |
| 2021-02-16 10:01 am Sale | 13G | ADAPTIVE BIOTECHNOLOGIES CORP ADPT | Matrix Capital Management Company LP | 13,115,090 9.59% | -4,217,101 (-24.33%) | View |
| 2021-02-12 7:38 pm Purchase | 13G | ADAPTIVE BIOTECHNOLOGIES CORP ADPT | VIKING GLOBAL INVESTORS LP | 29,993,708 21.9% | 13,611,045 (+83.08%) | View |
| 2021-02-10 10:30 am Purchase | 13G | ADAPTIVE BIOTECHNOLOGIES CORP ADPT | VANGUARD GROUP INC | 9,655,425 7.06% | 9,655,425 (New Position) | View |
| 2020-02-14 10:32 am Purchase | 13G | ADAPTIVE BIOTECHNOLOGIES CORP ADPT | Matrix Capital Management Company LP | 17,332,191 13.94% | 17,332,191 (New Position) | View |
| 2020-02-11 12:41 pm Purchase | 13G | ADAPTIVE BIOTECHNOLOGIES CORP ADPT | VIKING GLOBAL INVESTORS LP | 38,406,607 30.9% | 38,406,607 (New Position) | View |